(Press-News.org) INDIANAPOLIS -- Research from the Regenstrief Institute, the Indiana University Center for Aging Research and Wishard-Eskenazi Health on medications commonly taken by older adults has found that drugs with strong anticholinergic effects cause cognitive impairment when taken continuously for as few as 60 days. A similar impact can be seen with 90 days of continuous use when taking multiple drugs with weak anticholinergic effect.
The study of 3,690 older adults is among the first to explore how length of use of this group of drugs affects the brain. The study is available online in advance of publication in a print issue of Alzheimer's & Dementia, the journal of the Alzheimer's Association. The research was funded by a grant (R24MH080827) from the National Institute on Aging.
Anticholinergic drugs block acetylcholine, a nervous system neurotransmitter. Drugs with anticholinergic effects are sold over the counter and by prescription. Older adults commonly use over-the-counter drugs with anticholinergic effects as sleep aids and to relieve bladder leakage. Drugs with anticholinergic effects are frequently prescribed for many chronic diseases including hypertension, cardiovascular disease and chronic obstructive pulmonary disease.
A list of drugs noting their anticholinergic burden can be found on the Aging Brain Care website.
The Regenstrief Institute, IU Center for Aging Research and Wishard-Eskenazi Health researchers reported that continuously taking strong anticholinergics, like many sleeping pills or antihistamines, for only 60 days caused memory problems and other indicators of mild cognitive impairment. Taking multiple drugs with weaker anticholinergic effects, such as many common over-the-counter digestive aids, had a negative impact on cognition in 90 days.
"We found that a high anticholinergic burden -- either from one or multiple drugs -- plus two to three months of continuous exposure to that high burden approximately doubled the risk of developing cognitive impairment," said Noll Campbell, Pharm.D., study co-author and Regenstrief Institute investigator. "Millions of older adults are taking sleeping pills or prescription drugs year after year that may be impacting their organizational abilities and memory."
Dr. Campbell is also an IU Center for Aging Research scientist, a research assistant professor in the Department of Pharmacy Practice, Purdue University College of Pharmacy, and a clinical pharmacy specialist in geriatrics with Wishard-Eskenazi Health Services.
"While the link between anticholinergics and cognitive impairment has been reported by our group and others, the cumulative burden of anticholinergics was rather unexpected, as was the lack of a clear association between anticholinergic burden and dementia," said Regenstrief Institute investigator Malaz Boustani, M.D., MPH. Dr. Boustani, the senior author of the study, who is also associate director of the IU Center for Aging Research and an associate professor of medicine at IU School of Medicine. He sees patients at the Healthy Aging Brain Center at Wishard-Eskenazi Health.
"The fact that taking anticholinergics is linked with mild cognitive impairment, involving memory loss without functional disability, but not with Alzheimer's disease and other dementing disorders, gives hope. Our research efforts will now focus on whether anticholinergic-induced cognitive impairment may be reversible," Dr. Boustani said.
INFORMATION:
In addition to Drs. Campbell and Boustani, co-authors of "Long-term anticholinergic use and the aging brain" are Xueya Cai, Ph.D., formerly of the IU School of Medicine and now with the University of Rochester; Regenstrief investigator Babar Khan, M.D., IU Center for Aging Research scientist and IU School of Medicine assistant professor of medicine; and Regenstrief investigator Christopher Callahan, M.D., founding director of IU Center for Aging Research and Cornelius and Yvonne Pettinga Professor in Aging Research at the IU School of Medicine. Drs. Boustani, Kahn and Callahan see patients at Wishard-Eskenazi Health.
Study: Using anticholinergics for as few as 60 days causes memory problems in older adults
2013-05-07
ELSE PRESS RELEASES FROM THIS DATE:
The brain-gut connection: A link between depression and common hospital-acquired infection
2013-05-07
ANN ARBOR, Mich. — Adults with depression and who receive certain types of anti-depressants have an increased risk of developing Clostridium difficile, a costly and serious hospital-associated infection, according to a new University of Michigan Health System study.
Older Americans who were widowed and those who lived alone were also more likely to develop C. difficile, a bacterium that causes a growing number of serious infections in U.S. hospitals and nursing homes and is responsible for more than 7,000 deaths a year in the country. Symptoms range from diarrhea to ...
New lung cancer guidelines recommends offering screening to high-risk individuals
2013-05-07
(NORTHBROOK, IL, MAY 7, 2013) –The American College of Chest Physicians (ACCP) third edition of evidence-based lung cancer guidelines, Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, recommends offering low-dose computed tomography (LDCT) scanning for lung cancer screening to people with a significant risk of lung cancer due to age and smoking history.
Published as a special supplement to the May issue of CHEST, ACCP's peer-reviewed journal, the guidelines cite evidence to show lung cancer ...
Study demonstrates that once-a-day pill offers relief from ragweed allergy symptoms
2013-05-07
An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal congestion and itchy eyes experienced by ragweed allergy sufferers.
Tests showed that treatment with the pill, which contains the protein Ambrosia artemisiifolia major allergen 1, and is placed under the tongue to be absorbed, also reduced the need for anti-allergy drugs to get relief. More than 80 million Americans are allergic to ragweed.
The ...
Silk and cellulose biologically effective for use in stem cell cartilage repair
2013-05-07
Over 20 million people in Europe suffer from osteoarthritis which can lead to extensive damage to the knee and hip cartilage. Stem cells offer a promising way forward but a key challenge has been to design a 'smart material' that is biologically effective for cartilage tissue regeneration. Now researchers have identified a blend of naturally occurring fibres such as cellulose and silk that makes progress towards affordable and effective cell-based therapy for cartilage repair a step closer.
The EPSRC-funded study, published in Biomacromolecules and undertaken by University ...
Do bats know voices of friends they hang out with?
2013-05-07
VIDEO:
A bat reacts to contact call stimulus with a turning to the loudspeaker, placed on the right side.
Click here for more information.
Is it possible that mammals have the ability to recognize individuals of the same species, whom they know well, by their voice? A new study has found that even in nocturnal, fast-moving animals such as bats, there is an ability to recognize certain vocal aspects of other bats from their social groups. The study by Hanna Kastein from the University ...
All hospitals should require drug, alcohol tests for physicians
2013-05-07
To improve patient safety, hospitals should randomly test physicians for drug and alcohol use in much the same way other major industries in the United States do to protect their customers. The recommendation comes from two Johns Hopkins physicians and patient safety experts in a commentary published online April 29 in The Journal of the American Medical Association.
In addition, the experts say, medical institutions should take a cue from other high-risk industries, like airlines, railways and nuclear power plants, and mandate that doctors be tested for drug or alcohol ...
Spinal 'spacer' procedure has fewer complications, but higher risk of repeat surgery
2013-05-07
Philadelphia, Pa. (May 7, 2013) - Interspinous spacer implantation—a less-invasive alternative surgical option for spinal stenosis—has a lower complication rate than spinal fusion, reports a study in the May 1 issue of Spine The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
However, patients receiving interspinous spacers are more likely to require repeated back surgery, according to the report by Dr Ricard A. Deyo and colleagues of Oregon Health & Science University, Portland. They conclude, "Use of interspinous spacers poses ...
Another 'trophy' for the chemistry cabinet
2013-05-07
The search for cleaner, low temperature nuclear fuels has produced a shock result for a team of experts at The University of Nottingham.
First they created a stable version of a 'trophy molecule' that has eluded scientists for decades. Now they have discovered that the bonding within this molecule is far different than expected. Remarkably their findings have shown that it behaves in much the same way as its counterparts in the well-known transitional metals such as chromium, molybdenum and tungsten.
The research, done by PhD student David King, which could help in ...
New technique can help nanoparticles deliver drug treatments
2013-05-07
DETROIT — A Wayne State University researcher has successfully tested a technique that can lead to more effective use of nanoparticles as a drug delivery system.
Joshua Reineke, Ph.D., assistant professor of pharmaceutical sciences in the Eugene Applebaum College of Pharmacy and Health Sciences, examined how a biodegradable polymer particle called polylactic-co-glycolic acid (PLGA) breaks down in live tissue.
He believes the potential impact of his work is broad, as nanoparticles increasingly have been developed as carriers of drug treatments for numerous diseases ...
AGU journal highlights -- May 7, 2013
2013-05-07
The following highlights summarize research papers that have been recently
published in Journal of Geophysical Research-Solid Earth (JGR-B), Journal of
Geophysical Research-Oceans (JGR-C), Journal of Geophysical Research-Earth
Surface (JGR-F) and Tectonics.
In this release:
Graphite lubricates fault zones
Sediment processes can be significant source of ambient noise
Evolution of the Qin Mountains as part of the supercontinent Rodinia
Studying how flocculation affects acoustic reflection
How do braided river dynamics affect sediment storage?
Charting the ...